-
New cell-based study reveals autoimmune mechanism in DM2
A cell-based study revealed the biological mechanism behind the increased tendency for people with myotonic
-
Breaking news: Rare Disease Day Congressional Hearing to Address the BENEFIT Act
On Thursday, February 29th, Rare Disease Day, the House Energy and Commerce Committee will hold
-
In choosing a college, my son with DMD is already winning
I am a competitive former college athlete married to a someone who is equally competitive
-
Revised Community-Led Duchenne Guidance Published: Developing Potential Treatments for the Entire Spectrum of Disease
Today PPMD is pleased to share that the revised community-led Duchenne Guidance has been published
-
Exon-skipping AOC 1044 gets FDA rare pediatric disease status
The U.S. Food and Drug Administration (FDA) has granted rare pediatric disease designation to AOC
-
Watch: Overview of WVE-N531 and the FORWARD-53 Clinical Trial with Wave Life Sciences (Webinar Recording)
Wave Life Sciences recently joined PPMD for a community webinar to share an update on
-
I’m tapering off antidepressants and steroids with no regrets
On Feb. 19, I went to see my psychiatrist for the first time in 2024,
-
SAT-3247 improves muscle function in FSHD mouse model
SAT-3247, an oral therapy candidate for rebuilding muscle tissue, improved muscle function in a mouse
-
PPMD Announces Pediatric Certified Duchenne Care Center at Penn State Health Children’s Hospital
Today PPMD announced the expansion of our renowned Certified Duchenne Care Center (CDCC) Program with
-
Sarepta Therapeutics Announces U.S. FDA Acceptance of an Efficacy Supplement to Expand the ELEVIDYS Indication
The FDA will make a decision whether or not to grant full approval of Sarepta’s
